Healthcare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening;
including H.R.2407 - The Nancy Gardner Sewell Multi-Cancer Early Detection Screening Coverage Act; S.2085 - A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.
Medicare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening;
including H.R.2407 - The Nancy Gardner Sewell Multi-Cancer Early Detection Screening Coverage Act; S.2085 - A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.
Duration: April 13, 2020
to
present
General Issues: Health Issues , Medicare/Medicaid , Labor Issues/Antitrust/Workplace
Spending: about $850,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2020: House of Representatives, U.S. Senate
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Ashley Gunn
Special Asst to the President, Senior Director, White House Office of Cabinet Affairs
Jonathan Hiler
Director of Legislative Affairs, Office of the Vice President, Mike Pence; Legislative Director, Senator Tom Cotton; Legislative Director, Rep. Tom Cotton; Policy Advisor, Rep. Mike Pence; Policy Advisor, Rep. Jeb Hensarling.
Jeffrey Miller
n/a
Stephen Ruppel
n/a
Jessica Mandel
n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Miller Strategies, LLC lobbied for GRAIL, LLC , earning $60,000. The report was filed on April 22.
Original Filing: 301574256.xml
Lobbying Issues
Healthcare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening;
including H.R.2407 - The Nancy Gardner Sewell Multi-Cancer Early Detection Screening Coverage Act; S.2085 - A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Medicare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening;
including H.R.2407 - The Nancy Gardner Sewell Multi-Cancer Early Detection Screening Coverage Act; S.2085 - A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2023
In Q4, Miller Strategies, LLC lobbied for GRAIL, LLC , earning $60,000. The report was filed on Jan. 22.
Original Filing: 301538187.xml
Lobbying Issues
Healthcare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening;
including H.R.2407 - The Nancy Gardner Sewell Multi-Cancer Early Detection Screening Coverage Act; S.2085 - A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Medicare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening;
including H.R.2407 - The Nancy Gardner Sewell Multi-Cancer Early Detection Screening Coverage Act; S.2085 - A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2023
In Q3, Miller Strategies, LLC lobbied for GRAIL, LLC , earning $60,000. The report was filed on Oct. 20, 2023.
Original Filing: 301515289.xml
Lobbying Issues
Healthcare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening;
including H.R.2407 - The Nancy Gardner Sewell Multi-Cancer Early Detection Screening Coverage Act; S.2085 - A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Medicare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening;
including H.R.2407 - The Nancy Gardner Sewell Multi-Cancer Early Detection Screening Coverage Act; S.2085 - A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2023
In Q2, Miller Strategies, LLC lobbied for GRAIL, LLC , earning $60,000. The report was filed on July 20, 2023.
Original Filing: 301492019.xml
Lobbying Issues
Healthcare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening;
including H.R.2407 - The Nancy Gardner Sewell Multi-Cancer Early Detection Screening Coverage Act; S.2085 - A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Medicare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening;
including H.R.2407 - The Nancy Gardner Sewell Multi-Cancer Early Detection Screening Coverage Act; S.2085 - A bill to amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2023
In Q1, Miller Strategies, LLC lobbied for GRAIL, LLC , earning $60,000. The report was filed on April 20, 2023.
Original Filing: 301464330.xml
Lobbying Issues
Healthcare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening;
H.R.1946 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021; S. 1873 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening;
H.R.1946 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021; S. 1873 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2022
In Q4, Miller Strategies, LLC lobbied for GRAIL, LLC , earning $50,000. The report was filed on Jan. 19, 2023.
Original Filing: 301433834.xml
Lobbying Issues
Healthcare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening;
H.R.1946 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021; S. 1873 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Medicare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening;
H.R.1946 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021; S. 1873 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2022
In Q3, Miller Strategies, LLC lobbied for GRAIL, LLC , earning $50,000. The report was filed on Oct. 20, 2022.
Original Filing: 301417377.xml
Lobbying Issues
Healthcare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening;
H.R.1946 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021; S. 1873 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Medicare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening;
H.R.1946 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021; S. 1873 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2022
In Q2, Miller Strategies, LLC lobbied for GRAIL, LLC , earning $50,000. The report was filed on July 20, 2022.
Original Filing: 301393901.xml
Lobbying Issues
Healthcare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening;
H.R.1946 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021; S. 1873 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Medicare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening;
H.R.1946 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021; S. 1873 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2022
In Q1, Miller Strategies, LLC lobbied for GRAIL, LLC , earning $50,000. The report was filed on April 20, 2022.
Original Filing: 301366403.xml
Lobbying Issues
Healthcare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening;
H.R.1946 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021;
S. 1873 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Medicare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening;
H.R.1946 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021;
S. 1873 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2021
In Q4, Miller Strategies, LLC lobbied for GRAIL, LLC , earning $50,000. The report was filed on Jan. 20, 2022.
Original Filing: 301334622.xml
Lobbying Issues
Healthcare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening;
H.R.1946 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021;
S. 1873 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Medicare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening;
H.R.1946 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021;
S. 1873 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2021
In Q3, Miller Strategies, LLC lobbied for GRAIL, LLC , earning $50,000. The report was filed on Oct. 20, 2021.
Original Filing: 301313132.xml
Lobbying Issues
Healthcare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening;
H.R.1946 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021;
S.1873 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Medicare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening;
H.R.1946 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021;
S. 1873 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Issues related to the FTC, merger, and antitrust.
Type of Issue
Labor Issues/Antitrust/Workplace
2nd Quarter, 2021
In Q2, Miller Strategies, LLC lobbied for GRAIL, INC. , earning $50,000. The report was filed on July 19, 2021.
Original Filing: 301282303.xml
Lobbying Issues
Healthcare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening.
H.R.1946/S.1873 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Medicare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening.
H.R.1946/S.1873 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Antitrust issues related to the Federal Trade Commission
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Labor Issues/Antitrust/Workplace
1st Quarter, 2021
In Q1, Miller Strategies, LLC lobbied for GRAIL, INC. , earning $50,000. The report was filed on April 20, 2021.
Original Filing: 301264896.xml
Lobbying Issues
Healthcare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Medicare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2020
In Q4, Miller Strategies, LLC lobbied for GRAIL, INC. , earning $50,000. The report was filed on Jan. 20, 2021.
Original Filing: 301239825.xml
Lobbying Issues
Healthcare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Medicare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2020
In Q3, Miller Strategies, LLC lobbied for GRAIL, INC. , earning $50,000. The report was filed on Oct. 20, 2020.
Original Filing: 301224014.xml
Lobbying Issues
Healthcare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Medicare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2020
In Q2, Miller Strategies, LLC lobbied for GRAIL, INC. , earning $50,000. The report was filed on July 20, 2020.
Original Filing: 301201532.xml
Lobbying Issues
Healthcare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Medicare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2020
Miller Strategies, LLC filed a lobbying registration on April 16, 2020 to represent GRAIL, INC., effective April 13, 2020.
Original Filing: 301168886.xml
Issue(s) they said they’d lobby about: Healthcare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening. Medicare issues as they relate to oncology and early multi-cancer detection, including diagnostics and screening. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate